Join
Live feed
·
INSIDERFilingvia Quantisnow
Dicerna Pharmaceuticals, Inc. logo

SEC Form 4: Ciappenelli Robert D. converted options into 3,425 shares and covered exercise/tax liability with 1,241 shares, increasing direct ownership by 17% to 14,813 units to cover withholding tax

ByQuantisnow·Wall Street's wire, on your screen.
DRNA· Dicerna Pharmaceuticals, Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track DRNA (Dicerna Pharmaceuticals, Inc.) and more on Quantisnow.

SEC Form 4: Ciappenelli Robert D. converted options into 3,425 shares and covered exercise/tax liability with 1,241 shares, increasing direct ownership by 17% to 14,813 units to cover withholding tax | Quantisnow